Clinical-based Cell Therapies for Heart Disease
Darren Turner, B.A.,1 Angela C. Rieger, M.S., M.D.,1 Wayne Balkan, Ph.D.,1,2 and Joshua M. Hare, M.D.1,2,* Abstract Patients have an ongoing unmet need for effective therapies that reverse the cellular and functional damage associated with heart damage and disease. The discovery that ~1%–2% of adult cardiomyocytes turn over per year provided the impetus for treatments that stimulate endogenous repair […]